Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Single Cell Multiomics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for single-cell multiomics has experienced remarkable expansion, projecting a rise from $4.85 billion in 2025 to $5.92 billion in 2026, driven by a robust compound annual growth rate of 22.1%. This growth trajectory, observed over the historical period, is underpinned by several key factors including significant progress in single-cell sequencing technologies, a broadening scope of cancer research projects, escalating investment in life sciences endeavors, enhanced accessibility of advanced high-throughput analytical instruments, and increased financial support for academic investigations.
Anticipated to expand significantly over the forthcoming years, the market for single-cell multiomics is projected to reach $13 billion by 2030, demonstrating a compound annual growth rate of 21.7%. This upward trajectory is fueled by several key factors, including a heightened need for precision medicine solutions, greater integration within clinical research processes, the proliferation of platforms designed to merge multiomics data, augmented investment in pharmaceutical R&D, and ongoing enhancements in analytical precision. Key developments set to shape this market during the projected period involve a greater embrace of unified multiomics platforms, a surge in demand for detailed single-cell examinations, increased utilization of artificial intelligence for data interpretation, broader implementation of techniques for multi-modal cellular profiling, and a more pronounced focus on understanding cellular diversity.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp
Single Cell Multiomics Market Expansion Drivers: What Is Shaping Future Growth?
The market for single-cell multiomics is poised for expansion, driven by the escalating need for precision medicine. This approach to healthcare customizes treatments and strategies based on an individual’s unique biological makeup. The surge in precision medicine is attributable to breakthroughs in genetic research, improved data processing power, and a greater appreciation for the benefits of personalized care. By offering granular information on cellular variations and molecular processes, single-cell multiomics facilitates the creation of sophisticated, individualized therapies designed around a patient’s specific cellular makeup. Illustrating this trend, the Personalized Medicine Coalition (PMC) reported that in 2023, the U.S. Food and Drug Administration (FDA) authorized 18 new personalized medicines, representing approximately 38% of all new therapeutic compounds introduced that year. Consequently, the growing emphasis on precision medicine is a key catalyst for the advancement of the single-cell multiomics sector.
Single Cell Multiomics Market Segment Landscape: Which Areas Lead Market Development?
The single cell multiomics market covered in this report is segmented –
1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics
2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis
3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research
4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies
Subsegments:
1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms
2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms
3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools
4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools
Single Cell Multiomics Market Strategic Trends: What Is Defining The Next Phase Of Growth?
In the realm of single-cell multiomics, leading entities are actively engaged in creating advanced single-cell multiomics assays aimed at refining the precision and detail of cellular investigations. These sophisticated assays empower scientists to gain deeper insights into intricate biological mechanisms, pinpoint elusive cell types, and personalize therapeutic strategies by consolidating extensive molecular information derived from individual cells. As a concrete illustration, Mission Bio, a biotechnology firm situated in the United States, unveiled its Tapestri Single-cell Multiple Myeloma Multiomics Solution in June 2024. This groundbreaking offering facilitates an exhaustive examination of multiple myeloma at the individual cell level. Consequently, this solution equips researchers focusing on translational studies and those involved in drug development with the capability to thoroughly map the molecular and cellular intricacies throughout the progression of myeloid disorders, investigate mechanisms of treatment resistance, and pinpoint the fundamental factors driving disease evolution from its nascent phases, including conditions like monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Single Cell Multiomics Market Industry Leaders And Market Competition
Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS
Access The Complete Single Cell Multiomics Market Report:
https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report
Single Cell Multiomics Market Geographic Distribution And Regional Opportunities
North Americawas the largest region in the single cell multiomics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model